NRC Health (NRC) Dividend Safety
- Dividend payout ratio · 12 months: Value (m); Formula and calculation Cash dividends paid / net income. Period ending 2026-06-30..
Dividend safety
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Dividend payout ratio · 12 months | (m) | Cash dividends paid / net income. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Dividend payments · 12 months | (m) | |
| Net income · 12 months | 5.86M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Dividend payments · 12 months (USD) | Net income · 12 months (USD) | Dividend payout |
|---|---|---|---|
| 2026-06-30 | (m) | $5.86M | (m) |
| 2026-03-31 | (m) | $9.04M | (m) |
| 2025-12-31 | (m) | $11.60M | (m) |
| 2025-06-30 | (m) | (m) | (m) |
| 2025-03-31 | (m) | (m) | (m) |
| 2024-12-31 | (m) | $24.78M | (m) |
| 2023-12-31 | (m) | $30.97M | (m) |
| 2022-12-31 | (m) | $31.80M | (m) |
| 2021-12-31 | (m) | $37.47M | (m) |
| 2018-12-31 | (m) | $30.05M | (m) |
| 2018-09-30 | (m) | $28.76M | (m) |
| 2018-06-30 | (m) | $25.93M | (m) |
| 2018-03-31 | (m) | $23.73M | (m) |
| 2017-12-31 | (m) | $22.94M | (m) |
| 2017-09-30 | (m) | $22.15M | (m) |
| 2017-06-30 | (m) | $22.73M | (m) |
| 2017-03-31 | (m) | $21.53M | (m) |
| 2016-12-31 | (m) | $20.52M | (m) |
| 2016-09-30 | (m) | $20.72M | (m) |
| 2016-06-30 | (m) | $20.13M | (m) |
| 2016-03-31 | (m) | $19.30M | (m) |
| 2015-12-31 | (m) | $17.61M | (m) |
| 2015-09-30 | (m) | $15.78M | (m) |
| 2015-06-30 | (m) | $16.20M | (m) |
| 2015-03-31 | (m) | $16.18M | (m) |
| 2014-12-31 | (m) | $18.16M | (m) |
| 2014-09-30 | (m) | $17.82M | (m) |
| 2014-06-30 | (m) | $17.09M | (m) |
| 2014-03-31 | (m) | $16.47M | (m) |
| 2013-12-31 | (m) | $15.48M | (m) |
| 2013-09-30 | (m) | $15.42M | (m) |
| 2013-06-30 | (m) | $15.18M | (m) |
| 2013-03-31 | (m) | $15.69M | (m) |
| 2012-12-31 | (m) | $15.07M | (m) |
| 2012-09-30 | (m) | $14.50M | (m) |
| 2012-06-30 | (m) | $13.57M | (m) |
| 2012-03-31 | (m) | $11.96M | (m) |
| 2011-12-31 | (m) | $11.56M | (m) |
| 2011-09-30 | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) |
| 2010-12-31 | (m) | $8.50M | (m) |
| 2009-12-31 | (m) | $8.49M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |